Treatment of early insulinization with glargine in type 2 diabetes patients uncontrolled on sulfonylurea or metformin monotherapy

Trial Profile

Treatment of early insulinization with glargine in type 2 diabetes patients uncontrolled on sulfonylurea or metformin monotherapy

Completed
Phase of Trial: Phase IV

Latest Information Update: 23 Apr 2013

At a glance

  • Drugs Insulin glargine (Primary) ; Glibenclamide; Gliclazide; Glimepiride; Glipizide; Metformin
  • Indications Type 2 diabetes mellitus
  • Focus Therapeutic Use
  • Acronyms TARGET
  • Sponsors Sanofi
  • Most Recent Events

    • 06 Nov 2008 Actual end date (May 2008) added as reported by ClinicalTrials.gov.
    • 06 Nov 2008 Actual patient number (387) added as reported by ClinicalTrials.gov.
    • 06 Nov 2008 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top